ARCHIVES

Drug Development Committee Demands, Gets Greater Voice In Contract Awards, Review of Unsolicited Proposals, Suggests RFP For New Screening Systems

This article is from The Cancer Letter archive.

Vol. 02 No. 01 | January 2, 1976

Download PDF Visit The Full Archive

Related Articles

Celebrex Studies Show Polyp Reduction, Point To Challenges In Biomarker Validation

April 28, 2006

Oral Contraceptives Related To Liver Tumors; New Studies Urged

March 12, 1976

HHS Orders Gallo Forum Canceled; Meeting May Be Held After OSI report final – Calabresi

July 3, 1992

Zytiga and Prednisone Extends Overall Survival in mCRPC Trial

October 31, 2014

Q & A: NCI’s Doroshow Says Phase I Program Will Stress Correlative Studies for Small Biotech Firms

April 6, 2012

Roswell Park Celebrates 50th Anniversary of Pivotal Congressional Visit

October 20, 2021